Anavo Therapeutics
anavotx.com
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$54.2M
2 rounds on record
Latest round
$30.2M
Seed · May 2023 · 3 yr ago
Team
11-50
employees, estimated range
Backers
3
Inkef, M Ventures
The money's age
Long since its last round
41 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 22
Board appointment Anavo Therapeutics names Vincent Brichard as board chairman · thepharmaletter.com
May 2, 2023
Raised a round Seed $30.2M · DutchNews.nl
Apr 24, 2021
Launched Anavo Therapeutics launches to drug phosphatases · Chemical & Engineering News
Apr 21, 2021
Raised a round Seed $24M
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | May 2023 | $30.2M | — | DutchNews.nl |
| Seed | Apr 2021 | $24M | — | bioworld.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Inkef 
M Ventures 
Taiho Ventures Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Peptone applies machine learning and physics simulation to intrinsically disordered proteins, a class long considered undruggable. Founded…
Eureka Robotics is a deep-tech company that builds software giving industrial robots high accuracy and agility for delicate assembly tasks…
Light Horse is a small molecule drug discovery company that is leading the way in a.
Redefining Data Center Connectivity for the AI Era. Lucidean’s CohZero™ technology delivers coherent performance with zero…
Unlocking resiliencefor the chemical industry.
Meet Our Team. Atomistic Insights brings together leading experts in protein dynamics, drug discovery, and AI to unlock undruggable targets…
News
Anavo Therapeutics:€28 Million Seed Round Secured For Unlocking The Potential of Human Phosphatase Biology
Anavo Therapeutics - a global leader in unlocking the full therapeutic potential of human phosphatase biology - announced recently an€8.5 million seed round extension, adding MRL Ventures Fund as a new investor. And all existing investors, M Ventures, INK
Read more
Report
Daily News
The Los Angeles Daily News is the local news source for Los Angeles and the San Fernando Valley region, providing breaking news, sports, business, entertainment, things to do, opinion, photos, videos and more from L.A.
Read more
Report
Report
Anavo Therapeutics extends Seed Round to EUR 28 Million to Advance Pipeline of Novel Phosphatase Modulators Toward the Clinic
Anavo Therapeutics extends Seed Round to EUR 28 Million to Advance Pipeline of Novel Phosphatase Modulators Toward the Clinic
Read more
Report
Anavo Therapeutics extends Seed Round to EUR 28 Million to Advance Pipeline of Novel Phosphatase Modulators Toward the Clinic
Anavo Therapeutics extends Seed Round to EUR 28 Million to Advance Pipeline of Novel Phosphatase Modulators Toward the Clinic
Read more
Report
Anavo Therapeutics launches to drug phosphatases
Netherlands-based startup raised $24 million to tackle historically tough-to-target enzymes
Read more
Report
Anavo Therapeutics wants Big Pharma to dust off the shelves in search of phosphatase drugs
Read more
Report
Anavo Therapeutics closes $24M seed round to drug the phosphatome
DUBLIN - Anavo Therapeutics BV raised €20 million (US$24 million) in seed financing to fund the build-out of a platform that aims to drug the human phosphatome, or the ensemble of phosphatase enzymes that plays a crucial role in maintaining cells' phospho
Read more
Report